Objective: The response of the RV following treatment of aortic stenosis is poorly defined, reflecting the challenge of accurate RV assessment. Cardiovascular magnetic resonance (CMR) is the established reference for imaging of RV volumes, mass and function. We sought to define the impact of transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR) upon RV function in patients treated for severe aortic stenosis using CMR.
Right ventricular function following Surgical Aortic Valve Replacement and
Transcatheter Aortic valve implantation: a Cardiovascular MR study. 
INTRODUCTION
Surgical aortic valve replacement (SAVR) is first-line therapy for symptomatic patients with severe aortic valve stenosis. Transcatheter aortic valve implantation (TAVI) has emerged as a clinical and cost-effective treatment for patients deemed inoperable or with too high predicted mortality (1) . Reverse remodelling of the left ventricle observed following both TAVI and SAVR has been well documented (2) . However, much less is understood about the response of the right ventricle (RV) in these settings.
RV dysfunction is thought to occur following cardiac surgery for both valvular(3) and coronary disease (4) and is an independent predictor of late survival and adverse clinical outcomes (5) .
The precise mechanism of this dysfunction remains to be elucidated; a number of theories have been proposed based on conflicting evidence. The EuroSCORE II and the STS models for calculating operative mortality of cardiac surgery do not incorporate preoperative RV dysfunction, despite its' association with a high mortality (6) . This in part reflects the challenging nature of reliably evaluating RV performance(7) with its asymmetric and variable 3D geometry.
Cardiovascular magnetic resonance (CMR) is the established reference modality for imaging of both left and right ventricular volumes and function. CMR affords reproducible 3D volume acquisition, can image in any plane, has excellent blood-tissue contrast and can detect subtle wall motion abnormalities(8).
Studies directly comparing the impact of SAVR with TAVI upon RV function are limited(6, 9, 10) and have depended upon 2D transthoracic echocardiographic (TTE) parameters with relatively short follow-up. This study was designed specifically to determine the impact of SAVR and TAVI upon RV performance using CMR at 6 months. We hypothesised that SAVR, but not TAVI (which obviates the need of cardiopulmonary bypass and pericardiotomy), would be associated with decline in RV function. Furthermore, we sought to elucidate potential mechanisms, by defining the contribution of procedural factors and CMR derived parameters to any observed change in RV performance. Imaging, Calgary, Alberta, Canada -used for assessment of LGE). Standard ventricular and valvular assessment was performed as previously described(2).
METHODS

Study population
For patients in normal sinus rhythm, the left atrium emptying fraction was determined, defined as (LAVolmax -LAVolmin)x100/LAVolmax. Similarly, the right atrium emptying fraction was determined, defined as (RAVolmax -RAVolmin)x100/RAVolmax.
The tricuspid annular plane systolic excursion (TAPSE) was measured as the maximum apical displacement of the lateral tricuspid valve annulus from end-diastole to end-systole ( Figures   1A and 1B) . Delayed late gadolinium enhanced images were reviewed by two experienced observers for focal myocardial fibrosis and scarring (secondary to infarction) and then reported qualitatively, as either present or absent, and, for the LV, quantified using the full-width halfmaximum technique.
Statistical Analysis
Based on published data, 45 patients per group were required to detect a 7ml change in RVEDV or 2% difference in EF between the two treatments (80% power and an error of months apart) and inter-observer (12 data sets) agreement was assessed and expressed as coefficient of variation.
RESULTS
Patient population
A total of 112 patients (56 TAVI and 56 SAVR) completed both preoperative and 6 month postoperative scans. Reasons for non-completion of the CMR protocol were varied ( Figure 2 ).
Baseline characteristics of the final study population are reported in Table 1. TAVI patients were older, with a higher STS score and greater frequency of coronary intervention. There was no difference in baseline pulmonary pressure, as estimated by echocardiography, between the two intervention groups (p=0.159).
Procedural data 
Impact of intervention upon Right Ventricular size and function
No difference existed between the groups' preoperative indexed measurements of right ventricular EDV (p=0.547) or mass (p=0.462). Although both groups had preserved RV systolic function, the baseline RV ejection fraction (p=0.001) and TAPSE (p=0.026) were significantly higher in the SAVR group. SAVR, but not TAVI, was associated with a statistically significant decrease in RV ejection fraction with a concomitant increase in indexed RVESV at 6 months. Similarly post-operative SAVR TAPSE values were significantly lower than the TAVI group (p<0.001). The effect of intervention upon RV mass at 6 months was comparable between the two groups (p=0.259).
Late Gadolinium Enhancement
LGE imaging was performed in all but three TAVI patients, in whom renal impairment was prohibitive. For the TAVI group, 26(49%) had mid-wall/patchy LV fibrosis and 8(15%) prior myocardial infarction prior to intervention. Only 3(6%) patients had RV hyper-enhancement at baseline with no new cases seen at 6 months. For the SAVR group, 18(32%) had midwall/patchy LV fibrosis and 7(13%) had evidence of previous myocardial infarction. Only two SAVR patients had RV fibrosis at baseline and 4 (7%) had new hyper-enhancement at 6 months. No change in total quantity of scar (% LV myocardium) was seen following SAVR (2.4 vs 2.3%, p=0.759) or TAVI (3.1 vs 3.6%, p=0.795). In the subgroup of SAVR patients without baseline LV scar (n=31(55%)), no significant change was seen in RVEF post-operatively (56.9±7.8% vs. 53.0±8.8%, p=0.071).
Demographic and procedural risk factors associated with RV functional decline 
Measurement variability
Our variability in RV measurements was comparable to published values(8) ( Table 4) .
DISCUSSION
This prospective multicentre study, designed specifically to use CMR for the assessment of RV function in patients with symptomatic severe aortic stenosis, has shown that SAVR resulted in deterioration in RV systolic volumes and function, which was associated with longer surgical cross-clamp times. In contrast, RV volumes and systolic function were unaltered following TAVI.
The prognostic importance of the right ventricle and its contribution to exercise capacity in a number of cardiac conditions is well recognised(11). Recently it has been demonstrated that RV dysfunction is independently associated with late survival after left heart valve surgery(12).
There have been inconsistent findings from studies assessing RV function post-TAVI, in part due to the variety of echocardiographic definitions for systolic function being used(9, 10, 13).
Following SAVR however, an early decline in RV ejection fraction appears ubiquitous(6).
TAPSE has been the principal measurement studied in this context. However, TAPSE assessment maybe insensitive to global RV performance and is confounded by paradoxical interventricular septal motion, and particularly following SAVR, thoracic wall pericardial adhesions. Furthermore, TAPSE is an insensitive marker of RVEF unless it falls below 35% (14) . Even 3D echo can systematically underestimate RV volumes (15) , such that CMR is considered the reference investigation for RV morphological and functional assessment.
We have demonstrated using CMR that there is no change in RV volumes or ejection fraction at 6 months following TAVI. SAVR on the other hand is associated with a significant increase in RV end systolic volume, preserved end diastolic volume and overall reduction in ejection fraction. Consistent with this observation was a significant reduction in TAPSE.
CMR has previously been used to assess RV function in a comparison between off-pump and on-pump techniques for CABG (4) . CABG was associated with a significant reduction in RV function 6 days post-operatively which normalised by 6 months. This was independent of surgical technique and thus not compounded by the use of a cross-clamp or cardiopulmonary bypass. The early decline was due to a decrease in the RV end diastolic volume, with the indexed RV end systolic volume remaining unchanged. Our surgical group was on average ten years older than the previously studied CABG cohort with a larger baseline RVESVi.
Furthermore, there was no change in indexed LV volumes or mass seen in the CABG studies(4). This is very different to the reverse remodelling seen post-SAVR(2) and together suggests our SAVR cohort and the CABG group are not directly comparable.
Our study has uniquely combined CMR volumetric RV analysis with the measurement of TAPSE as part of a comprehensive assessment of systolic function. TAPSE measurement disregards RV dimensions and is less sensitive to subtle RV changes (14) . This is an important limitation to relying on TAPSE alone to assess treatment response. Our observed combined reduction in both TAPSE and volumetric ejection fraction following SAVR, and not TAVI, implies SAVR confers a genuine functional decline in RV systolic function, and not merely a geometric change post-operatively, such as that described following mitral valve surgery(11).
Our findings allow us to consider further the pathophysiology of RV deterioration observed following SAVR which remains poorly understood. In our study, LA emptying fraction did not change, mitral regurgitation decreased and LV ejection fraction improved 6 months following SAVR. These findings strongly suggest the pathophysiology of RV systolic decline post SAVR is independent of left heart function.
Our study indicates the increase in RVESV following SAVR is statistically significantly associated with longer aortic cross clamp times at surgery. This is a new, previously undescribed observation. Prolonged cardiopulmonary bypass time is associated with increased mortality and morbidity (16) . Longer cross-clamp times are associated with a greater risk of myocardial ischaemia (17) and raised biomarkers of myocardial damage (18) .
Tissue characterisation is a pivotal and unique strength of CMR. However, the thin RV wall, susceptibility to artefact and close association with pericardial fat are all limitations to LGE assessment. Nonetheless, we detected new infarction in only 7% of patients. This is, to our knowledge, the first study to utilise LGE in the assessment of RV response to surgery. Our findings suggest the decline in RV function we observed following SAVR is not fully explicable by suboptimal RV protection during cardiopulmonary bypass. The lack of association with bypass grafting at the time of surgery is also consistent with a process unrelated to epicardial coronary disease.
It is noteworthy that RV dysfunction post operatively is an adverse prognostic marker(5) and in a small study, patients without LV LGE had no 30-day MACCE events and no deaths up to 2 years following SAVR (19) . In our patients without baseline hyperenhancement, SAVR was not associated with a change in RV ejection fraction at 6 months. Further work is needed to investigate the potential role of CMR in risk stratifying patients that are potentially most susceptible to RV deterioration following aortic valve surgery.
Incision of the pericardium has been suggested as the principal factor responsible for RV deterioration post-cardiac surgery (20) . A significant decline in RV systolic tissue Doppler velocity occurs within minutes and is sustained, possibly through alterations in pericardial constraint and subsequently RV geometry (21) . Our findings of RV preservation following TAVI which obviates any pericardial insult, supports this hypothesis. Alternatively, a reduction in myocardial strain of the right atrium may confer a reduction in RV inlet long-axis systolic function post-SAVR (10). In experimental canine models, selective RA ischemic injury increases RV free wall dyskinesia (22) . The significant decline in RA emptying fraction following SAVR, and not TAVI, is likely a sequela to traumatic surgical venous cannulation and may contribute to the RV systolic decline observed at 6 months.
Previous studies demonstrating an early decline in RV function following cardiac surgery have implicated an increase in pulmonary vascular resistance(4). It is conceivable that such an increase in afterload could mediate RV dysfunction through end systolic cavity dilatation. The use of mechanical ventilation, anaesthesia and pro-inflammatory cytokines have all been implicated (23) . However, pulmonary vascular resistance is thought to normalize soon after surgery and thus unlikely to fully explain our findings at 6 months(24). Furthermore, crossclamping of the thoracic aorta significantly increases mean pulmonary arterial and pulmonary capillary wedge pressures (25) . Canine models suggest this is mediated through blood volume redistribution and increased afterload (26) . Such an afterload mismatch may contribute to the increased RVESV observed at 6 months and underscore the influence of aortic cross-clamp time at surgery.
The finding that RV mass at 6 months following TAVI is independently associated with allcause mortality is novel and most likely a reflection of worse outcome in those with right-sided pressure overload from more significant underlying pulmonary disease, despite the correction of aortic stenosis. Further work in a larger population is needed to clarify the prognostic value of CMR RV mass quantification in this context.
Study Limitations
Our study is not randomised and baseline differences in demographics between our study groups are unavoidable due to current TAVI implantation guidelines.
The higher mortality and pacing rates in the TAVI group may have a confounding effect, potentially excluding patients with worse cardiac function from the analysis. However, there was statistically no difference in the STS score between the included 56 TAVI patients and those that withdrew/died (n=18) (5.54±3.4% vs. 5.28±3.82%, p=0.791). Furthermore, RV function at baseline as assessed by CMR, was also equivalent between these two groups.
Our study did not include patients undergoing trans-apical TAVI or sutureless AVR. 
